NIV-NAVA versus NCPAP immediately after birth in premature infants: A randomized controlled trialShow others and affiliations
2022 (English)In: Respiratory Physiology & Neurobiology, ISSN 1569-9048, E-ISSN 1878-1519, Vol. 302, article id 103916Article in journal (Refereed) Published
Abstract [en]
Objective: To evaluate whether noninvasive-neurally adjusted ventilatory assist (NIV-NAVA) decrease respiratory efforts compared to nasal continuous positive airway pressure (NCPAP) during the first hours of life.
Methods: Twenty infants born between 28+0 and 31+6 weeks were randomized to NIV-NAVA or NCPAP. Positive end-expiratory pressure was constantly kept at 6 cmH(2)O for both groups and the NAVA level was 1.0 cmH(2)O/mu V for NIV-NAVA group. The electrical activity of diaphragm (Edi) were recorded for the first two hours.
Results: Peak and minimum Edi decreased similarly in both groups (P = 0.98 and P = 0.59, respectively). Leakages were higher in the NIV-NAVA group than in the NCPAP group (P < 0.001). The neural apnea defined as a flat Edi for >= 5 s were less frequent in NIV-NAVA group than in NCPAP group (P = 0.046).
Conclusions: Immediately applied NIV-NAVA in premature infants did not reduce breathing effort, measured as peak Edi. However, NIV-NAVA decreased neural apneic episodes compared to NCPAP.
Place, publisher, year, edition, pages
Elsevier BV Elsevier, 2022. Vol. 302, article id 103916
Keywords [en]
Non-invasive ventilation, Continuous positive airway pressure, Interactive ventilatory support, Apnea
National Category
Respiratory Medicine and Allergy Pediatrics
Identifiers
URN: urn:nbn:se:uu:diva-477747DOI: 10.1016/j.resp.2022.103916ISI: 000798314000005PubMedID: 35500883OAI: oai:DiVA.org:uu-477747DiVA, id: diva2:1673552
2022-06-212022-06-212024-01-15Bibliographically approved